ALQN Stock Chart & Stats
Currently, no data available
Please return soon. This page is being updated.
Bulls Say, Bears Say
Bulls Say
Revenue & Margin TrendsConsistent revenue expansion across 2022–2026 alongside improving EBIT margins indicates durable demand and operational leverage across ALS's diversified testing services. Higher, steady operating margins support sustainable cash generation and reinvestment capacity over the medium term.
Improving LeverageMaterial deleveraging meaningfully strengthens financial flexibility and reduces interest burden, allowing ALS to better fund strategic initiatives, M&A or withstand cyclical slowdowns without immediate refinancing pressure, improving balance-sheet resilience.
Cash Generation StrengthRising operating cash flow and a recovery in free cash flow indicate ALS’s core testing businesses convert revenue into real cash. Strong cash generation underpins capital spending, customer-facing investment, and consistent funding for dividends or strategic deals over the coming months.
Bears Say
Earnings VolatilityA severe net margin swing in 2024 shows susceptibility to one‑offs, below‑the‑line shocks or volatile end‑market demand. Such earnings unpredictability can hamper multi‑period planning, weaken confidence in recurring profitability and complicate longer‑term capital allocation decisions.
Inconsistent Cash ConversionVariable cash conversion indicates working‑capital swings or timing differences between billing and collections tied to sample volumes and contracts. This reduces the reliability of reported earnings as a funding source for dividends, buybacks, or acquisitions over the medium term.
Recent High Historical LeverageAlthough leverage has fallen, the near‑term history of elevated debt underscores balance‑sheet vulnerability during downturns. If margins or cash flows deteriorate, residual indebtedness could limit strategic optionality and increase refinancing risk over the next several quarters.
ALS News
ALQN FAQ
What was ALS Ltd.’s price range in the past 12 months?
Currently, no data Available
What is ALS Ltd.’s market cap?
ALS Ltd.’s market cap is $126.74B.
When is ALS Ltd.’s upcoming earnings report date?
ALS Ltd.’s upcoming earnings report date is Nov 23, 2026 which is in 119 days.
How were ALS Ltd.’s earnings last quarter?
ALS Ltd. released its earnings results on May 17, 2026. The company reported $4.882 earnings per share for the quarter, beating the consensus estimate of $4.748 by $0.134.
Is ALS Ltd. overvalued?
According to Wall Street analysts ALS Ltd.’s price is currently Undervalued.
Does ALS Ltd. pay dividends?
ALS Ltd. does not currently pay dividends.
What is ALS Ltd.’s EPS estimate?
ALS Ltd.’s EPS estimate is 5.08.
How many shares outstanding does ALS Ltd. have?
Currently, no data Available
What happened to ALS Ltd.’s price movement after its last earnings report?
ALS Ltd. reported an EPS of $4.882 in its last earnings report, beating expectations of $4.748. Following the earnings report the stock price went same N/A.
Which hedge fund is a major shareholder of ALS Ltd.?
Currently, no hedge funds are holding shares in MX:ALQN
What is the TipRanks Smart Score and how is it calculated?
Smart Score combines eight research factors - such as analyst recommendations, hedge fund trends, and technical indicators - to measure a stock’s outlook. These signals are unified into a single score that reflects bullish or bearish momentum. See detailed methodology
ALS Stock Smart Score
Outperform
1
2
3
4
5
6
7
8
9
10
Analyst Consensus
Moderate Buy
Average Price Target:
$294.00 (― Upside)
$294.00 (― Upside)
Insider Transactions
Bought Shares
Worth $90.2K over
the Last 3 Months
the Last 3 Months
Technicals
SMA
Positive
20 days / 200 days
Momentum
36.94%
12-Months-Change
Fundamentals
Return on Equity
―
Trailing 12-Months
Asset Growth
6.01%
Trailing 12-Months
Company Description
ALS Ltd.
ALS Limited delivers expert technical services globally, specializing in analytical testing, precise measurement, and comprehensive inspection across various sectors. Its operations span continents, encompassing Africa, Asia-Pacific, Europe, the Middle East, North Africa, and the Americas. The organization structures its operations into three core divisions: Life Sciences, Commodities, and Industrial. The Commodities division supports mining and mineral exploration firms by providing a comprehensive suite of services, including assaying, analytical testing, and metallurgy. These offerings cover geochemistry, metallurgy, inspection, and ensuring coal quality standards. Throughout the entire resource lifecycle, from initial exploration and feasibility studies to optimization, production, design, development, trade, and rehabilitation, this segment offers critical testing and advisory solutions. Furthermore, it handles coal sampling, analysis, certification, and evaluations of geological formations, alongside other associated analytical tests. The Life Sciences division focuses on the environmental, food, pharmaceutical, and consumer product sectors, delivering analytical testing, sampling, and remote monitoring. It conducts microbiological, physical, and chemical analyses. Moreover, this segment furnishes crucial analytical data to support consulting and engineering companies, various industries, and governmental bodies. The Industrial segment provides specialized diagnostic testing and engineering solutions tailored for the energy, resources, transportation, and infrastructure industries. It caters to a broad clientele, including asset owners, operational managers, construction firms, and equipment manufacturers across sectors such as power generation, petrochemicals, mining, mineral processing, water management, infrastructure development, and transportation. Established in 1863, the company, originally known as Campbell Brothers Limited, adopted its current name, ALS Limited, in August 2012. Its global operations are directed from its headquarters in Milton, Australia.
ALQN Company Deck
ALQN Earnings Call
Q4 2026
0:00 / 0:00